| Pharmaceutical Information |
| Drug Name |
Dinoprost |
| Drug ID |
BADD_D00682 |
| Description |
Dinoprost has been investigated in Headache. |
| Indications and Usage |
Not Available |
| Marketing Status |
approved; investigational |
| ATC Code |
G02AD01 |
| DrugBank ID |
DB12789
|
| KEGG ID |
D00081
|
| MeSH ID |
D015237
|
| PubChem ID |
5280363
|
| TTD Drug ID |
D00HTY
|
| NDC Product Code |
Not Available |
| UNII |
B7IN85G1HY
|
| Synonyms |
Dinoprost | PGF2 | Prostaglandin F2alpha | F2alpha, Prostaglandin | PGF2alpha | Prostaglandin F2 | Prostaglandin F2 alpha | F2 alpha, Prostaglandin | 9alpha,11beta-PGF2 | 9alpha,11beta PGF2 | PGF2 alpha | alpha, PGF2 | Estrofan | Enzaprost F |
|
| Chemical Information |
| Molecular Formula |
C20H34O5 |
| CAS Registry Number |
551-11-1 |
| SMILES |
CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
